The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Diflucan 150 mg hard capsules

Pfizer Healthcare IrelandPA0822/211/002

Main Information

Trade NameDiflucan 150 mg hard capsules
Active SubstancesFluconazole
Dosage FormCapsule, hard
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/211/002

Group Information

ATC CodeJ02AC Triazole derivatives
J02AC01 fluconazole


License statusAuthorised
Licence Issued05/08/1988
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListFluconazole 150mg Capsules
Interchangeable List CodeIC0151-062-001
Interchangeable List DocumentPDF of Interchangeable List
« Back